2021 annual financial data
Whitehawk Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -2,002.05%.
Operating income was -111,217,000 USD and net income was -110,090,000 USD.
Operating cash flow was -22,423,000 USD.
Get free Whitehawk Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,120,000 USD
- Operating income
- -111,217,000 USD
- Net income
- -110,090,000 USD
- Operating cash flow
- -22,423,000 USD